Antiepileptic drugs

Antiepileptic drugs

by Rene H. Levy

Join Readfeed freeFind clubs reading this
Rate this book:

Browse books you can read free on Readfeed

No club is reading this yet — be the first to start one

Start a club free
About
New edition of a reference for professionals involved with treating and researching epilepsy, as well as psychiatrists and clinicians who manage patients with bipolar disorder, migraine, neuropathic pain and other conditions for which these drugs are used. The 98 chapters by medical experts cover 16 drugs, even when benzodiapines, barbiturates and hydantoins are each counted as one drug. New information includes increased emphasis on clinical trials, the importance of patient factors for obtaining optimal results with drug therapy, status epilepticus, prevention of epileptogenesis, and indications outside of epilepsy. Edited by Levy (U. of Washington Schools of Pharmacy and Medicine), Richard H. Mattson (Yale U. School of Medicine), Brian S. Meldrum (Institute of Psychiatry, London) and Emilio Perucca (Institute of Neurolgy, Pavia). Annotation copyrighted by Book News, Inc., Portland, OR.

Discuss Antiepileptic drugs with other readers

Join or start a book club for Antiepileptic drugs on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.

Sign up freeBrowse book clubs

Frequently asked questions

How do I join a book club for Antiepileptic drugs?

Sign up free on Readfeed, then browse public clubs or start your own club with Antiepileptic drugs as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.

Can I discuss Antiepileptic drugs with other readers online?

Yes. Readfeed book clubs let you chat live, share progress, and join discussions about Antiepileptic drugs with readers worldwide — whether your club is virtual, in-person, or hybrid.

Is Readfeed free?

Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.